COPPI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.532
EU - Europa 2.333
AS - Asia 2.236
SA - Sud America 342
AF - Africa 90
Continente sconosciuto - Info sul continente non disponibili 79
OC - Oceania 25
Totale 7.637
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.446
RU - Federazione Russa 798
IT - Italia 689
CN - Cina 640
SG - Singapore 613
BR - Brasile 259
HK - Hong Kong 259
PL - Polonia 229
VN - Vietnam 201
KR - Corea 193
IE - Irlanda 143
SE - Svezia 82
DE - Germania 78
FR - Francia 77
IN - India 76
FI - Finlandia 72
BD - Bangladesh 57
GB - Regno Unito 51
CA - Canada 50
NL - Olanda 44
ID - Indonesia 42
PK - Pakistan 30
AR - Argentina 27
AU - Australia 25
IQ - Iraq 20
JP - Giappone 20
ES - Italia 19
JO - Giordania 19
EG - Egitto 16
MX - Messico 16
TR - Turchia 16
EC - Ecuador 14
CO - Colombia 12
MA - Marocco 11
NG - Nigeria 11
KE - Kenya 10
UA - Ucraina 10
CH - Svizzera 9
CZ - Repubblica Ceca 9
BJ - Benin 8
GH - Ghana 8
VE - Venezuela 7
PE - Perù 6
PH - Filippine 6
PY - Paraguay 6
ZA - Sudafrica 6
CL - Cile 5
IR - Iran 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CI - Costa d'Avorio 4
NP - Nepal 4
AZ - Azerbaigian 3
BB - Barbados 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KH - Cambogia 3
LT - Lituania 3
NO - Norvegia 3
SN - Senegal 3
SV - El Salvador 3
TN - Tunisia 3
AM - Armenia 2
BE - Belgio 2
BH - Bahrain 2
DZ - Algeria 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
MY - Malesia 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
IL - Israele 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
MZ - Mozambico 1
Totale 7.550
Salva come PNG Salva come JPEG
Città #
Santa Clara 613
Singapore 479
Ashburn 410
Hong Kong 233
Warsaw 227
Hefei 217
San Jose 195
Seoul 187
Dublin 143
Florence 113
Milan 108
Ho Chi Minh City 77
Beijing 75
Fairfield 74
Chandler 61
Rome 61
Council Bluffs 58
Los Angeles 54
Moscow 50
Munich 44
Lauterbourg 41
Hanoi 38
Buffalo 35
New York 35
Lawrence 32
Helsinki 31
The Dalles 31
Altamura 30
Jakarta 30
Wilmington 27
Houston 26
Kent 26
Seattle 25
Woodbridge 25
São Paulo 24
Lappeenranta 22
Melbourne 22
Phoenix 22
Boston 19
Dallas 19
Turku 19
Princeton 18
Cambridge 17
Tokyo 17
Mumbai 16
Shanghai 15
Frankfurt am Main 14
London 14
San Diego 14
Haiphong 12
West Jordan 12
Bengaluru 11
Paris 11
Turin 11
Delhi 10
Guangzhou 10
Lahore 10
Medford 10
Montreal 10
Bologna 9
Chicago 9
Naples 9
Shenzhen 9
Ann Arbor 8
Boardman 8
Cotonou 8
Da Nang 8
Nairobi 8
Toronto 8
Accra 7
Amsterdam 7
Casablanca 7
Chennai 7
Figino 7
Madrid 7
Pune 7
Quito 7
Atlanta 6
Biên Hòa 6
Cairo 6
Dong Ket 6
Düsseldorf 6
Hillsboro 6
Kırıkkale 6
Lagos 6
Mexico City 6
Orem 6
Redwood City 6
Abuja 5
Austin 5
Baghdad 5
Bern 5
Cagliari 5
Curitiba 5
Denver 5
Dhaka 5
Genoa 5
Hangzhou 5
Hải Dương 5
Multan 5
Totale 4.556
Salva come PNG Salva come JPEG
Nome #
Novel phenotypic and molecular approaches for tackling the problem of microbial drug resistance 386
A simple phenotypic method for screening of MCR-1-mediated colistin resistance 323
Citrobacter freundii resistant to novel β-lactamase inhibitor combinations and cefiderocol, co-producing class A, B and D carbapenemases encoded by transferable plasmids 242
Male reproductive system inflammation after healing from coronavirus disease 2019 213
Nosocomial outbreak by NDM-1-producing Klebsiella pneumoniae highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022 205
Multicenter evaluation of the RAPIDEC® CARBA NP test for rapid screening of carbapenemase-producing Enterobacteriaceae and Gram-negative nonfermenters from clinical specimens 205
A urokinase-associated outbreak of Ralstonia mannitolilytica bloodstream infections in haemodialysis patients in north-eastern Italy, January to April 2023 197
SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron 197
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 196
Reply: COVID-19: Semen impairment may not be related to the virus 191
Combination regimen of nirmatrelvir/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: A case report and a scoping review of the literature 189
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications 187
Novel resistance ICEs carrying the blaFIM-1 metallo-β-lactamase gene from an ST235 Pseudomonas aeruginosa sublineage 186
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients 185
Detection of poxtA2, a presumptive poxtA ancestor, in a plasmid from a linezolid-resistant enterococcus gallinarum isolate 183
Population structure of kpc carbapenemase-producing klebsiella pneumoniae in a long-term acute-care rehabilitation facility: Identification of a new lineage of clonal group 101, associated with local hyperendemicity 181
Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19 179
Rapid screening for SARS-CoV-2 VOC-Alpha (202012/01, B.1.1.7) using the Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay 179
Evaluation of the commercial AD fosfomycin test for susceptibility testing of multidrug-resistant Enterobacterales and Pseudomonas aeruginosa 178
Discrepancies in fosfomycin susceptibility testing of KPC-producing Klebsiella pneumoniae with various commercial methods 175
AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection 172
Variable performance of different commercial systems for testing carbapenem susceptibility of KPC carbapenemase-producing Escherichia coli 165
Evaluation of extraction-free RT-PCR methods for faster and cheaper detection of SARS-CoV-2 using two commercial systems 164
Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19 163
Isothermal microcalorimetry vs checkerboard assay to evaluate in-vitro synergism of meropenem-amikacin and meropenem-colistin combinations against multi-drug-resistant Gram-negative pathogens 161
Up-regulation of resident chromosomal fosB gene expression: a novel mechanism of acquired fosfomycin resistance in MRSA 160
Evaluation of Quantamatrix dRASTTM system for rapid antimicrobial susceptibility testing of bacterial isolates from positive blood cultures, in comparison with commercial Micronaut broth microdilution system 153
Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study 153
Evaluation of different molecular systems for detection and quantification of SARS-CoV-2 RNA from wastewater samples 151
Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening 147
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 144
Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates 139
Resistance and virulence features of hypermucoviscous Klebsiella pneumoniae from bloodstream infections: Results of a nationwide Italian surveillance study 138
Pseudomonas aeruginosa producing FIM-1-metallo-β-lactamase: emergence and cross-transmission in a long-term acute care rehabilitation hospital 138
A simple phenotypic method for screening of MCR-1-mediated colistin resistance 132
In vivo evolution to high-level cefiderocol resistance of NDM-1-producing Klebsiella pneumoniae, followed by intra-hospital cross-transmission 129
Ceftazidime-avibactam resistance associated with increased blaKPC-3 gene copy number mediated by pKpQIL plasmid derivatives in sequence type 258 Klebsiella pneumoniae 127
Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307 121
Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam 120
Chloramphenicol activity against carbapenemase producing Enterobacterales 118
Amelioration of Serum Aβ Levels and Cognitive Impairment in APPPS1 Transgenic Mice Following Symbiotic Administration 117
Ceftazidime-avibactam resistance associated with increased blaKPC-3 gene copy number mediated by pKpQIL plasmid derivatives in sequence type 258 Klebsiella pneumoniae 110
Off-label oritavancin treatment outcome and molecular characterization of a vancomycin- and linezolid-resistant Enterococcus faecium causing liver abscesses 102
Dealing with Challenges Posed by Antimicrobial Resistance in Long-Term Acute-Care Rehabilitation Facilities 99
Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing 93
Frequent carriage of enterococci and other Lactobacillales with OptrA and PoxtA ribosomal protection resistance mechanisms among children from rural areas of Bolivia 23
Clinical and microbiological analysis of bloodstream infections by four cefiderocol-resistant and not previously exposed NDM-producing Klebsiella pneumoniae 21
Totale 7.637
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.153
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022134 0 0 11 6 2 10 16 23 4 9 13 40
2022/2023427 32 104 29 24 10 67 73 10 47 7 11 13
2023/2024424 7 38 43 15 25 54 20 78 17 66 30 31
2024/20252.490 98 219 141 394 529 277 101 175 130 91 146 189
2025/20263.368 388 527 417 355 346 104 314 148 186 196 127 260
2026/2027339 126 76 137 0 0 0 0 0 0 0 0 0
Totale 7.637